Why AstraZeneca will be Pfizer's easiest takeover

Now watching

Next video starts in : 7 Play

Why AstraZeneca will be Pfizer's easiest takeover

Why AstraZeneca will be Pfizer's easiest takeover
Replay video
Up next

CEO To Cramer: Tech is changing business

Unlock your personal NFL Now stream by signing in to NFL.com

Why AstraZeneca will be Pfizer's easiest takeover

by CNBC Videos 3:36 mins

Raghuram Selvaraju, Head of Healthcare Equity Research at Aegis Capital, discusses Pfizer's motivations behind its takeover bid for U.K.-based AstraZeneca.

View Comments (1)